Summary:
Phase IIb/III, Randomized, Double-blind, Placebo Controlled
An Adaptive, phase 2b/3, Double-Blind, Randomized, Placebo controlled study to establish the dosage, efficacy, and safety of L-O-M® MCS in treating lower urinary tract symptoms suggestive of Benign Prostatic Hypeplasia.
Qualified Participants Must:
• Be male above 40 years of age
•
Have a diagnosis of enlarged prostate with nocturia (urinating 2 or more times a night)
Qualified Participants May Receive:
Medical care at no cost including:
- Study-related physical examination
- Laboratory blood analysis
- Investigational study drug to relieve enlarged prostate symptoms
Compensation for time & transportation